Skip to main content
. 2021 Nov 16;89(12):e00463-21. doi: 10.1128/IAI.00463-21

TABLE 2.

Pneumococcal strains used in this study

Strain Descriptiona Reference or source
TIGR4 Invasive clinical isolate, capsular serotype 4, sensitive to antibiotics 85
D39 Avery strain, clinical isolate, capsular serotype 2; sensitive to antibiotics 87
R6 D39-derivative unencapsulated laboratory strain, sensitive to antibiotics 87
R6ΔspxBΔlctO R6-derivative, hydrogen peroxide and autolysis deficient strain. 88
R6ΔlytAΔlytC R6-derivative, autolysis deficient strain 89
EF3030 Clinical isolate, capsular serotype 19F, sensitive to antibiotics 50, 90
S. pneumoniae ATCC 49619 Invasive reference strain, recommended by the CLSIb for antimicrobial-sensitive test serotype 19F American Type Culture Collection, 43
GA44288 Clinical isolate, capsular serotype 19A; ERY, TET, AMX, CXM, CLI, SXT, MEM, PEN, CRO, CTX 91
GA47281 Clinical isolate, capsular serotype 19F; ERY, TET, AMX, CXM, CLI, SXT, MEM, PEN, CRO, CTX 91
GA16833 Clinical isolate, capsular serotype 19F; ERY, TET, CXM 91
GA17227 Clinical isolate, capsular serotype 23F; ERY, TET 91
a

Resistance to amoxicillin (AMX), cefuroxime (CXM), ceftriaxone (CRO), cefotaxime (CTX), clindamycin (CLI), erythromycin (ERY), meropenem (MEM), penicillin (PEN), tetracycline (TET), trimethoprim-sulfamethoxazole (SXT).

b

CLSI, Clinical and Laboratory Standards Institute.